Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Haoning Zhu"'
Autor:
Chen Zhao, Li Li, Wei Yang, Wenliang Lv, Jian Wang, Jing Guo, Yu Dong, Nannan Shi, Cheng Lu, Zhiqiang Li, Zhan Shi, Renbo Chen, Ruili Huo, Qianzi Che, Yaxin Tian, Xinghua Xiang, Junhui Zhou, Yongjun Bian, Suping Chen, Yang Chen, Yingying Chen, Xiaodong Cong, Guoju Dong, Lijie Hu, Jianxin Jiang, Luxing Leng, Bin Li, Dongxu Li, Hao Li, Jing Li, Wensheng Qi, Qing Miao, Huaxin Shi, Jiaheng Shi, Bing Wang, Gang Wang, Wei Wang, Yongyue Xian, Xiaolei Xie, Chunyan Xu, Ming Xu, Bei Yan, Jinliang Yang, Li Zhang, Zhenqi Zhou, Haoning Zhu, Yibai Xiong, Bin Liu, Luqi Huang
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Previous research suggested that Chinese Medicine (CM) Formula Huashibaidu granule might shorten the disease course in coronavirus disease 2019 (COVID-19) patients. This research aimed to investigate the early treatment effect of Huashiba
Externí odkaz:
https://doaj.org/article/755338dbb672463db78f409d987d1fc6
Autor:
Lianguo Ruan, Ruili Huo, Chen Zhao, Yongjun Bian, Jia Liu, Ming Xu, Zhixu Yang, Yang Chen, Jing Guo, Xiaodong Cong, Bing Wang, Huaxin Shi, Lan-Ping Guo, Bei Yan, Dongxu Li, Suping Chen, Xiaolei Xie, Li Zhang, Chunyan Xu, Wenliang Lv, Guoju Dong, Jinliang Yang, Jian Wang, Zhenqi Zhou, Jianxin Jiang, Wei Yang, Haoning Zhu, Qing Miao, Luqi Huang, Xin Shen, Wensheng Qi, Hao Li, Jiaheng Shi, Gang Wang, Yongyue Xian, Luxing Leng, Bin Li, Jing Li, Yingying Chen, Yue Liu, Lijie Hu, Wei Wang, Cheng Lu
Publikováno v:
Phytomedicine
Objective To evaluate the efficacy and safety of Hua Shi Bai Du Granule (Q-14) plus standard care compared with standard care alone in adults with coronavirus disease (COVID-19). Study Design A single-center, open-label, randomized controlled trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c446585ae32a874294579951a0c43ba4
http://europepmc.org/articles/PMC8285932
http://europepmc.org/articles/PMC8285932
Autor:
Lijie Hu, Wei Yang, Hao Li, Xiaodong Cong, Jiaheng Shi, Yongyue Xian, Ruili Huo, Xin Shen, Jian Wang, Jianxin Jiang, Luxing Leng, Wensheng Qi, Jing Guo, Wei Wang, Cheng Lv, Lan-Ping Guo, Bei Yan, Chen Zhao, Jia Liu, Yue Liu, Gang Wang, Dongxu Li, Zhixu Yang, Bin Li, Jinliang Yang, Zhenqi Zhou, Wenliang Lv, Lianguo Ruan, Haoning Zhu, Li Zhang, Xiaolei Xie, Guoju Dong, Yingying Chen, Chunyan Xu, Yongjun Bian, Ming Xu, Suping Chen, Qing Miao, Yang Chen, Bing Wang, Huaxin Shi, Luqi Huang, Jing Li
OBJECTIVETo evaluate the efficacy and safety of Chinese medicine (Q-14) plus standard care compared with standard care alone in adult with coronavirus disease 2019 (COVID-19).Study DESIGNSingle-center, open label, randomised controlled trial.SETTINGW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc2421435e965535ed6548c91a0a7e64
https://doi.org/10.1101/2021.01.25.21249417
https://doi.org/10.1101/2021.01.25.21249417
Autor:
Jiaheng Shi, Xiaodong Cong, Lijie Hu, Zhenqi Zhou, Yongyue Xian, Jinliang Yang, Qing Miao, Yingying Chen, Jian Wang, Haoning Zhu, Jing Guo, Dongxu Li, Nannan Shi, Cheng Lu, Suping Chen, Lanping Guo, Hao Li, Jianxin Jiang, Renbo Chen, Wei Wang, Yongjun Bian, Yaxin Tian, Yang Chen, Chunyan Xu, Luxing Leng, Li Zhang, Bin Liu, Bing Wang, Huaxin Shi, Zhan Shi, Bin Li, Ming Xu, Yibai Xiong, Li Li, Wenliang Lv, Bei Yan, Wensheng Qi, Jing Li, Gang Wang, Guoju Dong, Jia Liu, Xiaolei Xie, Luqi Huang
Publikováno v:
Phytomedicine
Background Treatments for coronavirus disease 2019 (COVID-19) are limited by suboptimal efficacy. Methods From January 30, 2020 to March 23, 2020, we conducted a non-randomised controlled trial, in which all adult patients with laboratory-confirmed C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::980465e94276a43c02457b2e2c3a497c
https://pubmed.ncbi.nlm.nih.gov/33260064
https://pubmed.ncbi.nlm.nih.gov/33260064